Bacteriological Testing Market By Product (Instruments, Test Kits, Consumable Reagents); By Bacteria (Salmonella, Coliform, Listeria, Legionella, Campylobacter, Others); By Technology (Traditional, Rapid); By End User (Food and Beverage, Pharmaceutical, Cosmetics & Personal Care, Water, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
The Global Bacteriological Testing Market size was valued at USD 16,553.3 million in 2018, rising to USD 24,798.7 million in 2024, and is anticipated to reach USD 44,396.7 million by 2032, at a CAGR of 7.61% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Bacteriological Testing Market Size 2024
USD 24,798.7 Million
Bacteriological Testing Market, CAGR
7.61%
Bacteriological Testing Market Size 2032
USD 44,396.7 Million
The Global Bacteriological Testing Market is shaped by strong competition among multinational leaders and regional specialists. Major players include Thermo Fisher Scientific Inc., Eurofins, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Merck KGaA, Intertek, Neogen Corporation, BioMerieux, ALS Ltd., Symbio Labs, Alfa Chemistry, and Vimta Labs. These companies drive growth through advanced testing instruments, rapid diagnostic kits, automation, and compliance-driven services tailored for food, pharmaceutical, and water industries. Asia Pacific emerged as the leading region in 2024, holding 35% of the global share, supported by its expanding food processing base, pharmaceutical manufacturing, and regulatory initiatives.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
The Global Bacteriological Testing Market grew from USD 16,553.3 million in 2018 to USD 24,798.7 million in 2024, and is projected at USD 44,396.7 million by 2032, expanding at a 61% CAGR.
Instruments led with 42% share in 2024, supported by automation and advanced laboratory use, while test kits held 34% and consumable reagents accounted for 24%, driven by recurring demand.
Salmonella testing dominated with 29% share in 2024, followed by Coliform at 22% and Listeria at 18%, reflecting strict regulations and increasing foodborne illness concerns.
Rapid technology commanded 63% share in 2024, driven by demand for faster results across food, pharmaceutical, and water industries, while traditional testing retained 37% for confirmatory diagnostics.
Asia Pacific led with 35% share in 2024, followed by North America at 27% and Europe at 22%, highlighting strong growth in food processing, pharmaceutical production, and regulatory compliance.
Market Segment Insights
By Product
Instruments dominate the global bacteriological testing market with a 42% revenue share in 2024, supported by automation, advanced detection technologies, and widespread adoption in laboratories. Their accuracy and ability to handle high testing volumes strengthen their market leadership. Test kits hold 34% share, driven by rising demand for user-friendly and rapid detection tools across food and healthcare applications. Consumable reagents account for 24% share, fueled by their recurring use in testing processes, ensuring consistent demand and revenue stability.
For instance, Thermo Fisher Scientific launched the Applied Biosystems QuantStudio 7 Pro Dx Real-Time PCR System, designed to deliver high-throughput bacterial pathogen detection for clinical labs.
By Bacteria
Salmonella remains the leading bacteria segment with a 29% market share in 2024, driven by rising global foodborne illness cases and mandatory testing in poultry and meat industries. Coliform testing captures 22% share, widely used in water and beverage industries to ensure public health safety. Listeria represents 18% share, supported by stringent monitoring in dairy and processed food products. Legionella and Campylobacter together contribute 23% share, while others account for 8%, addressing specific regional and industrial requirements.
For instance, Neogen Corporation launched its Reveal 3-D for Salmonella test designed for rapid on-site detection in poultry and meat, streamlining mandatory food safety testing.
By Technology
Rapid technology leads the market with a 63% share in 2024, reflecting demand for faster, reliable results in food safety, pharmaceutical, and water testing applications. Its adoption is encouraged by growing regulatory pressure to minimize contamination risks and enhance testing efficiency. Traditional technology, holding a 37% share,
continues to serve laboratories requiring confirmatory diagnostics and research precision. Although slower, it remains valued for accuracy in established testing environments, particularly in academic, government, and resource-limited regions where cost-efficiency is critical.
Key Growth Drivers
Rising Food Safety Concerns
Foodborne illnesses continue to rise globally, making bacteriological testing a critical requirement for food and beverage industries. Governments and regulatory bodies enforce stringent standards, particularly for Salmonella, Listeria, and Coliform detection, to reduce contamination risks. Growing consumer awareness of food safety further pushes manufacturers to invest in advanced testing technologies. The increasing volume of processed and packaged foods worldwide also creates strong demand for rapid, accurate bacteriological tests, establishing food safety regulations as a primary growth driver for the market.
For instance, 3M Food Safety expanded its molecular detection system to cover Salmonella, enabling faster pathogen testing workflows for food producers.
Expanding Pharmaceutical and Healthcare Applications
The pharmaceutical sector heavily relies on bacteriological testing to ensure product safety, sterility, and compliance with global health regulations. Rising production of biologics, vaccines, and injectable drugs increases the demand for microbial quality control. Healthcare settings also emphasize bacterial testing to minimize risks of hospital-acquired infections and support patient safety. The global rise in antibiotic resistance further highlights the importance of routine bacteriological testing in healthcare. This expanding application base strengthens market growth by driving adoption of both rapid and traditional testing solutions.
For instance, Mayo Clinic Laboratories has implemented advanced bacterial typing by whole genome sequencing to monitor and mitigate outbreaks of methicillin-resistant Staphylococcus aureus (MRSA) in neonatal intensive care units, helping to identify carriers and prevent infection spread from 2014 to 2017.
Advancements in Testing Technologies
Innovations in testing methods, including automation, molecular diagnostics, and biosensor-based solutions, have significantly improved efficiency and reliability. Rapid testing technologies now dominate due to their ability to deliver accurate results within hours rather than days. Automation reduces human error while supporting large-scale testing in industries such as food processing, pharmaceuticals, and water treatment. Continuous R&D investments from major players also foster integration of AI and digital platforms for real-time monitoring. These technological advancements remain a key driver, fueling market expansion and wider adoption.
Key Trends & Opportunities
Shift Toward Rapid Testing Solutions
The global market is witnessing a clear shift toward rapid bacteriological testing, which accounted for over 60% of the market share in 2024. Industries prefer these solutions for faster turnaround, regulatory compliance, and efficiency in high-volume testing. The trend aligns with the growing need for real-time monitoring in food and pharmaceutical supply chains. Portable and easy-to-use rapid kits are also enabling testing in remote or resource-limited areas. This ongoing transition creates opportunities for innovation and adoption of next-generation diagnostic platforms.
For instance, the QuickMIC system from Gradientech received FDA Breakthrough Device Designation. It uses a microfluidic approach for antibiotic susceptibility testing, providing precise minimum inhibitory concentration values to optimize patient dosing and accelerate testing turnaround.
Emergence of Digital and Automated Platforms
Integration of digital solutions, robotics, and AI into bacteriological testing workflows is creating new opportunities. Automated systems enhance accuracy, reduce manpower costs, and enable continuous monitoring across industrial and healthcare applications. Cloud-based data platforms support traceability and regulatory reporting, making them attractive for compliance-driven industries. As industries expand globally, the demand for harmonized, digitally connected testing infrastructure grows. This trend fosters collaboration between diagnostic companies and technology providers, opening avenues for innovative product development and market penetration.
For instance, BD (Becton, Dickinson and Company) introduced the BD Kiestra™ IdentifA, an automated preparation system linked to AI-enabled MALDI-TOF workflows, reducing manual interventions in bacteriology testing and enhancing throughput in hospital laboratories.
Key Challenges
High Cost of Advanced Testing Solutions
Despite their benefits, advanced bacteriological testing technologies involve high capital and operational costs. Instruments and automated platforms require significant upfront investment, making adoption difficult for small and medium enterprises. Consumables and reagents add recurring expenses, creating cost barriers in developing regions. While rapid tests promise efficiency, their affordability remains a concern. Limited budgets in public health and small-scale food producers further restrict widespread adoption. Addressing cost-effectiveness will be crucial for expanding the market reach across all industry verticals.
Shortage of Skilled Professionals
Bacteriological testing requires trained professionals capable of operating advanced instruments and interpreting results accurately. However, many developing regions face a shortage of qualified microbiologists and lab technicians. The lack of expertise hinders adoption of modern technologies and slows down testing efficiency. Even with automation, professional oversight remains essential for confirmatory diagnostics and compliance reporting. Bridging the skills gap through training programs, academic collaborations, and industry initiatives is vital for sustaining growth and ensuring consistent quality outcomes in testing processes.
Regulatory and Standardization Barriers
The bacteriological testing market operates under diverse regulatory frameworks that vary across regions, creating compliance challenges. Harmonizing global standards remains complex, as countries enforce different testing requirements for food, pharmaceuticals, and water. Delays in regulatory approvals can restrict the launch of innovative technologies, slowing adoption. Inconsistent regulations also pose difficulties for companies aiming for global market expansion. Addressing these barriers through international collaborations, standardized protocols, and supportive regulatory environments is critical for unlocking the full potential of market growth.
Regional Analysis
North America
North America accounted for 27% of the global market in 2024, with revenue rising from USD 4,538.93 million in 2018 to USD 6,776.44 million in 2024, and projected to reach USD 12,075.90 million by 2032 at a CAGR of 7.6%. The region benefits from stringent food safety regulations, advanced healthcare infrastructure, and strong pharmaceutical production. The U.S. dominates due to large-scale adoption of rapid testing technologies and robust R&D activities. Rising demand for compliance-driven solutions in Canada and Mexico further strengthens North America’s leadership in the global bacteriological testing market.
Europe
Europe represented 22% of the global market in 2024, growing from USD 3,659.94 million in 2018 to USD 5,375.66 million in 2024, and expected to reach USD 9,367.70 million by 2032, at a CAGR of 7.3%. Strong regulatory frameworks, especially in Germany, France, and the UK, drive testing adoption across food, beverage, and water industries. The region’s advanced laboratory infrastructure and emphasis on product traceability support continued market expansion. Demand for rapid testing kits is accelerating as manufacturers aim to meet EU food safety directives, while pharmaceutical and cosmetic industries add further growth momentum.
Asia Pacific
Asia Pacific held the 35% share in 2024, making it the largest regional market. Revenues increased from USD 5,757.25 million in 2018 to USD 8,719.59 million in 2024, and are projected to reach USD 15,836.30 million by 2032, reflecting a CAGR of 7.8%. Growth is fueled by rapid urbanization, rising food consumption, and increasing government focus on food safety and healthcare quality. China, Japan, and India dominate demand with strong pharmaceutical industries and large food processing bases. Expanding water quality monitoring and growing adoption of rapid testing technologies further reinforce the region’s leadership position.
Latin America
Latin America contributed 9% of the market in 2024, with revenue rising from USD 1,474.90 million in 2018 to USD 2,240.39 million in 2024, and projected at USD 4,084.50 million by 2032, at a CAGR of 7.9%. Brazil leads the region, supported by its large food and beverage industry and expanding healthcare sector. Growing government investments in food safety testing and water quality assessments are driving demand. Rising adoption of rapid diagnostic kits and increased focus on export-oriented food industries are expected to accelerate growth, strengthening Latin America’s emerging role in the global bacteriological testing market.
Middle East
The Middle East accounted for 5% of the global market in 2024, with revenue increasing from USD 791.25 million in 2018 to USD 1,209.82 million in 2024, and expected to reach USD 2,224.27 million by 2032, growing at a CAGR of 8.0%, the highest among all regions. GCC countries dominate demand due to strong investments in food safety, water testing, and healthcare. The region’s rising dependence on imported food products and increasing regulatory enforcement drive adoption of rapid testing methods. Partnerships with global diagnostic companies further support technological advancement and market penetration.
Africa
Africa held 2% of the market in 2024, with revenue expanding from USD 331.07 million in 2018 to USD 476.84 million in 2024, and projected to reach USD 808.02 million by 2032, at a CAGR of 6.9%. Growth is supported by rising awareness of foodborne diseases, increasing healthcare investments, and international aid programs promoting water quality testing. South Africa remains the key contributor, followed by Egypt, while other regions are gradually adopting testing technologies. Limited infrastructure and high costs pose challenges, yet opportunities exist in portable rapid kits that provide accessible solutions for resource-constrained settings.
Market Segmentations:
By Product
Instruments
Test Kits
Consumable Reagents
By Bacteria
Salmonella
Coliform
Listeria
Legionella
Campylobacter
Others
By Technology
Traditional
Rapid
By End User
Food and Beverage
Pharmaceutical
Cosmetics & Personal Care
Water
Others
By Region
North America (U.S., Canada, Mexico)
Europe (UK, France, Germany, Italy, Spain, Russia, Rest of Europe)
Asia Pacific (China, Japan, South Korea, India, Australia, Southeast Asia, Rest of Asia Pacific)
Latin America (Brazil, Argentina, Rest of Latin America)
Middle East (GCC Countries, Israel, Turkey, Rest of Middle East)
Africa (South Africa, Egypt, Rest of Africa)
Competitive Landscape
The global bacteriological testing market is highly competitive, characterized by the presence of multinational corporations and specialized regional players. Leading companies such as Thermo Fisher Scientific Inc., Eurofins, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Merck KGaA, Intertek, Neogen Corporation, and BioMerieux dominate through extensive product portfolios, advanced technologies, and strong global distribution networks. These players focus on innovation, automation, and rapid testing platforms to meet regulatory standards across industries including food, pharmaceuticals, and water. Regional firms like ALS Ltd., Symbio Labs, Alfa Chemistry, and Vimta Labs strengthen their positions by offering cost-effective solutions tailored to local markets. Strategic initiatives such as mergers, acquisitions, and partnerships are common, enabling companies to expand their geographic reach and technological capabilities. Continuous investment in R&D, integration of digital platforms, and compliance-driven services remain central to competitive differentiation, shaping the market’s dynamic landscape and driving long-term growth opportunities.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In June 2025, bioMérieux acquired Day Zero Diagnostics’ assets to enhance sequencing and ML-based diagnostic tools.
In September 2025, LuminUltra Technologies Ltd. acquired GL Biocontrol to strengthen its European water diagnostics portfolio.
In February 2025, Biolog, Inc. purchased Anaerobe Systems, Inc., adding anaerobic bacterial culture media to its expertise.
In early 2025, Mérieux NutriSciences completed the acquisition of Bureau Veritas’ food testing business across Canada, the U.S., and other regions.
Report Coverage
The research report offers an in-depth analysis based on Product, Bacteria, Technology, End User and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
Demand for rapid testing methods will continue to expand across industries.
Food safety regulations will drive increased adoption of advanced testing solutions.
Pharmaceutical and healthcare applications will remain major growth contributors.
Integration of automation and digital platforms will improve testing efficiency.
Emerging economies will witness accelerated adoption due to rising awareness.
Portable and user-friendly test kits will gain popularity in resource-limited regions.
Strategic partnerships will enhance global reach and product innovation.
Water quality monitoring will create new opportunities for market players.
R&D investments will strengthen technological advancement and product pipelines.
Competition between multinational leaders and regional firms will intensify further.
CHAPTER NO. 1 : GENESIS OF THE MARKET
1.1 Market Prelude – Introduction & Scope
1.2 The Big Picture – Objectives & Vision
1.3 Strategic Edge – Unique Value Proposition
1.4 Stakeholder Compass – Key Beneficiaries CHAPTER NO. 2 : EXECUTIVE LENS
2.1 Pulse of the Industry – Market Snapshot
2.2 Growth Arc – Revenue Projections (USD Million)
2.3. Premium Insights – Based on Primary Interviews CHAPTER NO. 3 : BACTERIOLOGICAL TESTING MARKET FORCES & INDUSTRY PULSE
3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown CHAPTER NO. 4 : KEY INVESTMENT EPICENTER
4.1 Regional Goldmines – High-Growth Geographies
4.2 Product Frontiers – Lucrative Product Categories
4.3 Technology Sweet Spots – Emerging Demand Segments CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING
5.1 Momentum Metrics – Forecast & Growth Curves
5.2 Regional Revenue Footprint – Market Share Insights
5.3 Segmental Wealth Flow – Product, Bacteria, Technology, & End User Revenue CHAPTER NO. 6 : TRADE & COMMERCE ANALYSIS
6.1. Import Analysis By Region
6.1.1. Global Bacteriological Testing Market Import Revenue By Region
6.2. Export Analysis By Region
6.2.1. Global Bacteriological Testing Market Export Revenue By Region CHAPTER NO. 7 : COMPETITION ANALYSIS
7.1. Company Market Share Analysis
7.1.1. Global Bacteriological Testing Market: Company Market Share
7.2. Global Bacteriological Testing Market Company Revenue Market Share
7.3. Strategic Developments
7.3.1. Acquisitions & Mergers
7.3.2. New Product Launch
7.3.3. Regional Expansion
7.4. Competitive Dashboard
7.5. Company Assessment Metrics, 2024 CHAPTER NO. 8 : BACTERIOLOGICAL TESTING MARKET – BY PRODUCT SEGMENT ANALYSIS
8.1. Bacteriological Testing Market Overview By Product Segment
8.1.1. Bacteriological Testing Market Revenue Share By Product
8.2. Instruments
8.3. Test Kits
8.4. Consumable Reagents CHAPTER NO. 9 : BACTERIOLOGICAL TESTING MARKET – BY BACTERIA SEGMENT ANALYSIS
9.1. Bacteriological Testing Market Overview By Bacteria Segment
9.1.1. Bacteriological Testing Market Revenue Share By Bacteria
9.2. Salmonella
9.3. Coliform
9.4. Listeria
9.5. Legionella
9.6. Campylobacter
9.7. Others CHAPTER NO. 10 : BACTERIOLOGICAL TESTING MARKET – BY TECHNOLOGY SEGMENT ANALYSIS
10.1. Bacteriological Testing Market Overview By Technology Segment
10.1.1. Bacteriological Testing Market Revenue Share By Technology
10.2. Traditional
10.3. Rapid CHAPTER NO. 11 : BACTERIOLOGICAL TESTING MARKET – BY END USER SEGMENT ANALYSIS
11.1. Bacteriological Testing Market Overview By End User Segment
11.1.1. Bacteriological Testing Market Revenue Share By End User
11.2. Food and Beverage
11.3. Pharmaceutical
11.4. Cosmetics & Personal Care
11.5. Water
11.6. Others CHAPTER NO. 12 : BACTERIOLOGICAL TESTING MARKET – REGIONAL ANALYSIS
12.1. Bacteriological Testing Market Overview By Region Segment
12.1.1. Global Bacteriological Testing Market Revenue Share By Region
12.1.2. Regions
12.1.3. Global Bacteriological Testing Market Revenue By Region
12.1.4. Product
12.1.5. Global Bacteriological Testing Market Revenue By Product
12.1.6. Bacteria
12.1.7. Global Bacteriological Testing Market Revenue By Bacteria
12.1.8. Technology
12.1.9. Global Bacteriological Testing Market Revenue By Technology
12.1.10. End User
12.1.11. Global Bacteriological Testing Market Revenue By End User CHAPTER NO. 13 : NORTH AMERICA BACTERIOLOGICAL TESTING MARKET – COUNTRY ANALYSIS
13.1. North America Bacteriological Testing Market Overview By Country Segment
13.1.1. North America Bacteriological Testing Market Revenue Share By Region
13.2. North America
13.2.1. North America Bacteriological Testing Market Revenue By Country
13.2.2. Product
13.2.3. North America Bacteriological Testing Market Revenue By Product
13.2.4. Bacteria
13.2.5. North America Bacteriological Testing Market Revenue By Bacteria
13.2.6. Technology
13.2.7. North America Bacteriological Testing Market Revenue By Technology
13.2.8. End User
13.2.9. North America Bacteriological Testing Market Revenue By End User
13.3. U.S.
13.4. Canada
13.5. Mexico CHAPTER NO. 14 : EUROPE BACTERIOLOGICAL TESTING MARKET – COUNTRY ANALYSIS
14.1. Europe Bacteriological Testing Market Overview By Country Segment
14.1.1. Europe Bacteriological Testing Market Revenue Share By Region
14.2. Europe
14.2.1. Europe Bacteriological Testing Market Revenue By Country
14.2.2. Product
14.2.3. Europe Bacteriological Testing Market Revenue By Product
14.2.4. Bacteria
14.2.5. Europe Bacteriological Testing Market Revenue By Bacteria
14.2.6. Technology
14.2.7. Europe Bacteriological Testing Market Revenue By Technology
14.2.8. End User
14.2.9. Europe Bacteriological Testing Market Revenue By End User
14.3. UK
14.4. France
14.5. Germany
14.6. Italy
14.7. Spain
14.8. Russia
14.9. Rest of Europe CHAPTER NO. 15 : ASIA PACIFIC BACTERIOLOGICAL TESTING MARKET – COUNTRY ANALYSIS
15.1. Asia Pacific Bacteriological Testing Market Overview By Country Segment
15.1.1. Asia Pacific Bacteriological Testing Market Revenue Share By Region
15.2. Asia Pacific
15.2.1. Asia Pacific Bacteriological Testing Market Revenue By Country
15.2.2. Product
15.2.3. Asia Pacific Bacteriological Testing Market Revenue By Product
15.2.4. Bacteria
15.2.5. Asia Pacific Bacteriological Testing Market Revenue By Bacteria
15.2.6. Technology
15.2.7. Asia Pacific Bacteriological Testing Market Revenue By Technology
15.2.8. End User
15.2.9. Asia Pacific Bacteriological Testing Market Revenue By End User
15.3. China
15.4. Japan
15.5. South Korea
15.6. India
15.7. Australia
15.8. Southeast Asia
15.9. Rest of Asia Pacific CHAPTER NO. 16 : LATIN AMERICA BACTERIOLOGICAL TESTING MARKET – COUNTRY ANALYSIS
16.1. Latin America Bacteriological Testing Market Overview By Country Segment
16.1.1. Latin America Bacteriological Testing Market Revenue Share By Region
16.2. Latin America
16.2.1. Latin America Bacteriological Testing Market Revenue By Country
16.2.2. Product
16.2.3. Latin America Bacteriological Testing Market Revenue By Product
16.2.4. Bacteria
16.2.5. Latin America Bacteriological Testing Market Revenue By Bacteria
16.2.6. Technology
16.2.7. Latin America Bacteriological Testing Market Revenue By Technology
16.2.8. End User
16.2.9. Latin America Bacteriological Testing Market Revenue By End User
16.3. Brazil
16.4. Argentina
16.5. Rest of Latin America CHAPTER NO. 17 : MIDDLE EAST BACTERIOLOGICAL TESTING MARKET – COUNTRY ANALYSIS
17.1. Middle East Bacteriological Testing Market Overview By Country Segment
17.1.1. Middle East Bacteriological Testing Market Revenue Share By Region
17.2. Middle East
17.2.1. Middle East Bacteriological Testing Market Revenue By Country
17.2.2. Product
17.2.3. Middle East Bacteriological Testing Market Revenue By Product
17.2.4. Bacteria
17.2.5. Middle East Bacteriological Testing Market Revenue By Bacteria
17.2.6. Technology
17.2.7. Middle East Bacteriological Testing Market Revenue By Technology
17.2.8. End User
17.2.9. Middle East Bacteriological Testing Market Revenue By End User
17.3. GCC Countries
17.4. Israel
17.5. Turkey
17.6. Rest of Middle East CHAPTER NO. 18 : AFRICA BACTERIOLOGICAL TESTING MARKET – COUNTRY ANALYSIS
18.1. Africa Bacteriological Testing Market Overview By Country Segment
18.1.1. Africa Bacteriological Testing Market Revenue Share By Region
18.2. Africa
18.2.1. Africa Bacteriological Testing Market Revenue By Country
18.2.2. Product
18.2.3. Africa Bacteriological Testing Market Revenue By Product
18.2.4. Bacteria
18.2.5. Africa Bacteriological Testing Market Revenue By Bacteria
18.2.6. Technology
18.2.7. Africa Bacteriological Testing Market Revenue By Technology
18.2.8. End User
18.2.9. Africa Bacteriological Testing Market Revenue By End User
18.3. South Africa
18.4. Egypt
18.5. Rest of Africa CHAPTER NO. 19 : COMPANY PROFILES
19.1. ALS Ltd
19.1.1. Company Overview
19.1.2. Product Portfolio
19.1.3. Financial Overview
19.1.4. Recent Developments
19.1.5. Growth Strategy
19.1.6. SWOT Analysis
19.2. Thermo Fisher Scientific Inc.
19.3. Eurofins
19.4. Agilent Technologies Inc.
19.5. Bio-Rad Laboratories Inc.
19.6. Intertek
19.7. Merck kGaA
19.8. Neogen Corporation
19.9. Vimta Labs
19.10. BioMerieux
19.11. Symbio Labs
19.12. Alfa Chemistry
19.13. Other Key Players
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the current market size for Global Bacteriological Testing Market, and what is its projected size in 2032?
The Global Bacteriological Testing Market size reached USD 24,798.7 million in 2024 and is projected to attain USD 44,396.7 million by 2032, reflecting steady growth.
At what Compound Annual Growth Rate is the Global Bacteriological Testing Market projected to grow between 2025 and 2032?
The Global Bacteriological Testing Market is expected to expand at a CAGR of 7.61% during the forecast period 2025–2032, supported by regulatory requirements and technological innovations.
Which Global Bacteriological Testing Market segment held the largest share in 2024?
Instruments dominated the Global Bacteriological Testing Market in 2024 with a 42% revenue share, followed by test kits at 34%, supported by automation and laboratory adoption.
What are the primary factors fueling the growth of the Global Bacteriological Testing Market?
Key factors include rising food safety concerns, expanding healthcare and pharmaceutical applications, and advancements in rapid testing technologies, driving adoption across multiple industries globally.
Who are the leading companies in the Global Bacteriological Testing Market?
Major companies include Thermo Fisher Scientific Inc., Eurofins, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Merck KGaA, Intertek, Neogen Corporation, BioMerieux, ALS Ltd., and Symbio Labs.
Which region commanded the largest share of the Global Bacteriological Testing Market in 2024?
The Asia Pacific region led with 35% share in 2024, supported by strong food processing industries, pharmaceutical growth, and government initiatives for food and water safety.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The U.S. Bacteriological Testing Market size was valued at USD 3,333.84 million in 2018, reaching USD 4,877.10 million in 2024, and is anticipated to achieve USD 8,453.13 million by 2032, at a CAGR of 7.13% during the forecast period.
The Global Elderberry Supplements Market size was valued at USD 304.20 million in 2018 to USD 470.33 million in 2024 and is anticipated to reach USD 868.71 million by 2032, at a CAGR of 7.42% during the forecast period.
The pharmaceutical software market size was valued at USD 33.79 billion in 2024 and is anticipated to reach USD 64.41 billion by 2032, at a CAGR of 8.4 % during the forecast period (2024-2032).
The Tooth Filling Materials Market is projected to witness significant growth, with revenues expected to surge from USD 1,147.70 million in 2023 to USD 1,288 million by 2032, reflecting a compound annual growth rate of 2.3%.
The laboratory plastic consumable market size was valued at USD 16.47 billion in 2024 and is anticipated to reach USD 31.51 billion by 2032, at a CAGR of 8.45 % during the forecast period (2024-2032).
The on site preventive care market size was valued at USD 39.67 billion in 2024 and is anticipated to reach USD 60.41 billion by 2032, at a CAGR of 5.4% during the forecast period (2024-2032).
The OTC vitamins dietary supplements market is projected to witness substantial growth, with its value expected to surge from USD 89,997.70 million in 2023 to USD 180,997.70 million by 2032, reflecting a robust CAGR of 5.9%.
The Medical Adhesive Tapes Market is projected to witness significant growth, with its value expected to surge from USD 9,297.70 million in 2023 to USD 14,498 million by 2032, at a steady CAGR of 5.6%.
The Contrast Media Market is projected to experience substantial growth, with revenues expected to surge from USD 4,697.70 million in 2023 to USD 6,497.70 million by 2032, representing a compound annual growth rate of 3.6%.
The Cervical Total Disc Replacement (CTDR) market has experienced remarkable growth, with its value skyrocketing from $796 million USD in 2023 to a projected $24,422 million USD by 2032, reflecting an impressive Compound Annual Growth Rate (CAGR) of 11.60%.
The market for capillary blood collection devices has seen significant growth, reaching USD 1,797.70 million in 2023 and is expected to reach USD 3,397.70 million by 2032, with a steady Compound Annual Growth Rate (CAGR) of 7.6%.
The Aseptic Sampling Market is projected to $3,397.70 million USD by 2032, marking a robust Compound Annual Growth Rate (CAGR) of 7.6%.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$6999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
